Highly Efficient Genome Editing of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9

Gundry, Michael C., Brunetti, Lorenzo, Lin, Angelique, Mayle, Allison E., Kitano, Ayumi, Wagner, Dimitrios, Hsu, Joanne I., Hoegenauer, Kevin A. +3 more·2016·Cell Reports
DOI 10.1016/j.celrep.2016.09.092

Cited by (264)

Items 201–264 of 264

  1. CRISPR-Cas9-Mediated Knock-In Approach to Insert the GFP11 Tag into the Genome of a Human Cell Line
    Ryo Tamura, Daichi Kamiyama · 2022 · Methods in molecular biology
  2. CRISPR/Cas9-mediated Genome Editing: In vivo Review
    Narges Lotfalizadeh, Soheil Sadr, Pouria Ahmadi Simab, Ashkan Hajjafari, Hassan Borji, Zeynab Bayat · 2022 · Journal of Lab Animal Research
  3. Engineering megabase-sized genomic deletions with MACHETE (Molecular Alteration of Chromosomes with Engineered Tandem Elements)
    Francisco M. Barriga, Scott W. Lowe · 2024 · Nature Protocols
  4. Caspase-2 is essential for proliferation and self-renewal of nucleophosmin-mutated acute myeloid leukemia
    Dharaniya Sakthivel, Alexandra N. Brown-Suedel, Karla E. Lopez, Suruchi Salgar, Luiza E. Coutinho, Francesca Keane, Shixia Huang, Kenneth Mc Sherry, Chloé I. Charendoff, Kevin P. Dunne et al. · 2024 · Science Advances
  5. Combinatorial gene targeting in primary human hematopoietic stem and progenitor cells
    Alexandra Bäckström, David Yudovich, Kristijonas Žemaitis, Ludvig Nilsén Falck, Agatheeswaran Subramaniam, Jonas Larsson · 2022 · Scientific Reports
  6. CHEK2 loss endows chemotherapy resistance to hematopoietic stem cells
    Jing Zhou, Tianyuan Hu, D. Li, Sanming Li, Minhua Li, Xiangguo E. Shi, Daisuke Nakada · 2026 · Leukemia
  7. Base Editing of Human Hematopoietic Stem Cells
    Jing Zeng, Gabriele Casirati, My Anh Nguyen, Pietro Genovese, Daniel E. Bauer · 2023 · Methods in molecular biology
  8. CRISPR/Cas9-mediated gene disruption determines the roles of MITF and CITED2 in human mast cell differentiation
    Jiezhen Mo, Fredrik Wermeling, Gunnar P. Nilsson, Joakim S. Dahlin · 2024 · Blood Advances
  9. Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
    Chi‐Keung Cheng, Terry H. Y. Wong, Yuk‐Lin Yung, Nelson C. N. Chan, Margaret H.L. Ng · 2019 · Journal of Visualized Experiments
  10. Stress hematopoiesis induces a proliferative advantage in TET2 deficiency
    Vinothkumar Rajan, Keon Collett, Rachel Woodside, Sergey V. Prykhozhij, Michelle Moksa, Annaïck Carles, Marcus Wong, Mira F. Liebman, Martin Hirst, Jason N. Berman · 2021 · Leukemia
  11. Development of novel quality control material based on CRISPR/Cas9 editing and xenografts for MLH1 protein deficiency testing
    Rui Li, Runling Zhang, Ping Tan, Meng Wang, Yuqing Chen, Jiawei Zhang, Dongsheng Han, Yanxi Han, Jinming Li, Rui Zhang · 2021 · Journal of Clinical Laboratory Analysis
  12. Versatile and efficient non-viral integration of large transgenes in human T cells via CRISPR knock-in and engineered integrases
    Isabell Kassing, Jonas Kath, Ana-Maria Nitulescu, Viktor Glaser, Laura Marie Hartmann, Yaolin Pu, Luis Huth, Roberts Kārkliņš, Shona Maria Shaji, Alessa R. Ringel et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  13. Studying the cellular efficacy and tolerability of using CRISPR-gRNA ribonucleoprotein (RNP) complex for in-vitro knockdown of TRIB2 in acute myeloid leukaemia (AML) cells as preliminary clinical evaluations
    Josephine You Pheng Tan, Ramesh Thevendran, Yek Song Quek, Maheswaran Solayappan · 2025 · Molecular Biology Reports
  14. Establishment of a reverse genetics system for studying human immune functions in mice
    Priya Pal, Shuai Gao, Hongbo Gao, Xiwen Qin, Marina Cella, Qiankun Wang, Liang Shan · 2025 · Science Advances
  15. Forward and Reverse Genetics of B Cell Malignancies: From Insertional Mutagenesis to CRISPR-Cas
    Joanna Dawes, Anthony G. Uren · 2021 · Frontiers in Immunology
  16. CRISPR Gene Editing of Hematopoietic Stem and Progenitor Cells
    Reza Shahbazi, Patricia Lipson, Karthikeya S.V. Gottimukkala, Daniel D. Lane, Jennifer E. Adair · 2022 · Methods in molecular biology
  17. CRISPR/Cas9-mediated Cxcr4 Disease Allele Inactivation for Gene Therapy in a Mouse Model of WHIM Syndrome
    Ji‐Liang Gao, Albert Owusu-Ansah, Alexander Y. Yang, Erin Yim, David H. McDermott, Paejonette Jacobs, Shamik Majumdar, Uimook Choi, Colin L. Sweeney, Harry L. Malech et al. · 2023 · Blood
  18. Multiplex gene editing models of del(7q) reveal combined CUX1 and EZH2 loss drives clonal expansion and drug resistance
    Matthew R. M. Jotte, Angela Stoddart, Tanner C. Martinez, Raven Moten, Yuqing Xue, Molly K. Imgruet, Hunter Z. Blaylock, Henna S. Nam, Bonnie Y. Hu, Jermaine Austin et al. · 2025 · Blood Neoplasia
  19. Human T cell development notched up a level
    Anne‐Catherine Dolens, Tom Taghon · 2017 · Nature Methods
  20. Noncoding RNA and Epigenetic Change in Hematopoietic Stem Cell Aging
    David Garrick, Antoine David, Christelle Freitas, Dounia Djeghloul, Michèle Goodhardt · 2019 · Springer eBooks
  21. Development of a three-dimensional haematopoietic stem cell-permissive bone marrow niche model using magnetic levitation
    Natasha S. Lewis · 2018 · Enlighten: Theses (The University of Glasgow)
  22. CIS checkpoint deletion enhances the fitness of cord blood derived natural killer cells transduced with a chimeric antigen receptor
    May Daher, Rafet Başar, Elif Gokdemir, Natalia Baran, Nadima Uprety, Ana Karen Nunez Cortes, Mayela Carolina Mendt, Lucila Nassif Kerbauy, Pinaki Prosad Banerjee, Mayra Hernandez Sanabria et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  23. A novel human fetal liver-derived model reveals that MLL-AF4 drives a distinct fetal gene expression program in infant ALL
    Siobhan Rice, Thomas Jackson, Nicholas T. Crump, Nicholas Fordham, Natalina Elliott, Sorcha O’Byrne, Sarah Inglott, Dariusz Ładoń, Gary Wright, Jack Luke Bartram et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  24. Knockout studies using CD34+ hematopoietic cells suggest that CD44 is a physiological human neutrophil E-selectin ligand
    Yuqi Zhu, Sriram Neelamegham · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  25. Can Ruxolitinib Crash TET2 - and IDH2 -Driven Clonal Hematopoiesis?
    Elmira Khabusheva, Margaret A. Goodell · 2024 · Cancer Discovery
  26. Novel Pathway and Recent Advances for Targeting Sickle Cell Anemia through Novel Drug Delivery System
    Sanjeeb Chouhan, M. Ajazuddin, Parag Jain · 2024 · Cardiovascular & Hematological Agents in Medicinal Chemistry
  27. Computational design of synthetic receptors with programmable signalling activity for enhanced cancer T cell therapy
    Jan A. Rath, Lucas S. P. Rudden, Nazila Nouraee, Tiffany X. Y. Que, Christine Von Gunten, Cynthia Pérez, Flora Birch, Yashashvi Bhugowon, Andreas Füglistaler, Aisima Chatzi Souleiman et al. · 2025 · Nature Biomedical Engineering
  28. A dihydrouracil CRBN ligand mitigates IMiD associated safety liabilities in heterobifunctional targeted protein degrader
    Monica C. Rodrigo-Brenni, Jasper C. Komen, Ghaith M. Hamza, Natacha Bohin, Tomas Adomavicius, Angelo Andres, Stefan Blaho, Ulf Börjesson, Gavin W. Collie, Gian Marco De Donatis et al. · 2026 · Nature Communications
  29. Trisomy 8 alters chromatin conformations and activates Y chromosome genes in stem cells to drive a pre-leukemic state
    Jie Bai, Kimi Araki, Daisuke Kurotaki, Eerdunduleng, Supannika Sorin, Kei Hiramatsu, Narumi Uno, Ai Hamashima, Mihoko Iimori, Kenta Kikuchi et al. · 2026 · Oncogene
  30. Mechanotransduction through LFA-1 controls upstream migration in the KG-1a stem cell line
    Ai Mochida, Emily Valerio, Janis K. Burkhardt, Daniel A. Hammer · 2026 · Journal of Cell Science
  31. Hacking hematopoiesis – emerging tools for examining variant effects
    Michael C. Gundry, Vijay G. Sankaran · 2023 · Disease Models & Mechanisms
  32. Gene Editing in Hematopoietic Stem Cells
    Jiaoyang Liao, Yuxuan Wu · 2023 · Advances in experimental medicine and biology
  33. Gentherapie von Hämoglobinkrankheiten – aktuelle Konzepte und Herausforderungen
    Andreas E. Kulozik, Joachim B. Kunz · 2019 · Transfusionsmedizin
  34. Technologies, Tools, and Genetic Models to Study Osteoclasts
    Jean Vacher, Lina Saad, Monica Pata · 2019 · Elsevier eBooks
  35. Chromosome 9p21.3 Coordinates Cell Intrinsic and Extrinsic Tumor Suppression
    Francisco M. Barriga, Kaloyan M. Tsanov, Yu-Jui Ho, Noor Sohail, Amy Xin Wei Zhang, Timour Baslan, Alexandra N. Wuest, Isabella S. Del Priore, Brigita Meškauskaitė, Geulah Livshits et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  36. Correction of Griscelli Syndrome Type 2 causing mutations in the RAB27A gene with CRISPR/Cas9
    Özgür Doğuş Erol, Şimal Şenocak, Burcu Özçimen, Gülen Güney-Esken, Hasan Basri Kılıç, Çetin Kocaefe, Niek Peter van Til, Fatima Aerts‐Kaya · 2024 · TURKISH JOURNAL OF BIOLOGY
  37. Noncoding RNA and Epigenetic Change in Hematopoietic Stem Cell Aging
    David Garrick, Antoine David, Christelle Freitas, Dounia Djeghloul, Michèle Goodhardt · 2017 · Springer eBooks
  38. Therapeutic gene editing in hematopoietic progenitor cells from a mouse model of Fanconi anemia
    María José Pino-Barrio, Yari A. Gimenez, M Villanueva, Marcus Hildenbeutel, Rebeca Sánchez‐Domínguez, Sandra Rodríguez, Roser M. Pujol, Jordi Surrallés, Paula Rı́o, Toni Cathomen et al. · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  39. Enhancing the Efficiency of CRISPR/Cas9 Precise Gene Editing for Cystic Fibrosis Gene Therapy
    Kyle E. Seigel · 2018 · TSpace (University of Toronto)
  40. Measure Twice, Cut Once: Therapeutic Editing of HSPCs Requires Precise Planning
    Rachel E. Rau, Margaret A. Goodell · 2019 · Cell stem cell
  41. Optimized guide RNA selection recommendations for using sp Cas9 gene editing in human hematopoietic stem and progenitor cells
    Han J. M. P. Verhagen, Carlijn Kuijk, Anne M. Kokke, Laurens Rutgers, Santhe A. van der Meulen, Gerard J. van Mierlo, Carlijn Voermans, Emile van den Akker · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  42. Engineered stem cells combine stem cell and gene therapy approaches to move intestine therapy from bench to bed
    Mahmoud Shaaban Mohamed, Mahmoud I. Elbadry, Chao‐Ling Yao · 2021 · Elsevier eBooks
  43. Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
    Chi‐Keung Cheng, Terry H. Y. Wong, Yuk‐Lin Yung, Nelson C. N. Chan, Margaret H.L. Ng · 2019 · Journal of Visualized Experiments
  44. Efficient repair of human homozygous genetic mutation by CRISPR/Cas9 mediated interlocus gene conversion
    Fei Yang, Jingtao Pang, Guolong Liu, Yang Yang, Shenguang Qin, Ying Zhang, Yongrong Lai, Dan Liang, Yuxuan Wu · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  45. Genome Editing to Abrogate Muscle Atrophy
    Tingting Yang, Priyanka Gokulnath, Xinxiu Meng, Guoping Li, Junjie Xiao · 2022 · Advances in experimental medicine and biology
  46. CRISPR/Cas9 system in hematopoietic stem cells: Basic research and clinical applications
    Esra Albayrak · 2023 · Journal of Experimental and Clinical Medicine
  47. Reactivate expression of fetal hemoglobin In CD34+ primary adult erythroid cells by gene therapy
    Netchanok Leela-adisorn · 2016
  48. CRISPR/Cas9 gene editing for treating gene and protein disorders
    Chukwuebuka Emmanuel Umeyor, Preeya Negi, Riya Agarwal, Sonali Nitin Hanjankar, Vandana Bharat Patravale · 2025 · Elsevier eBooks
  49. Establishment of a Reverse Genetics System for the Study of Human Immune Functions in Mice
    Priya Pal, Shuai Gao, Hongbo Gao, Marina Cella, Qiankun Wang, Liang Shan · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  50. TTLL4 glutamyltransferase is a therapeutic target for NPM1-mutated acute myeloid leukemia
    Alexandra Schurer, Humaira Ilyas, Maxim I. Maron, Subray S. Hegde, Melissa R. Leyden, Irene Mariam Roy, Rotila Hyka, Lucas Dada, Jeffrey Shabanowitz, Donald F. Hunt et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  51. JARID2 inhibition reprograms human hematopoietic progenitor cells to enhance bone marrow transplantation
    Wentao Han, Hassan Bjeije, Hamza Celik, Michael P. Rettig, Nancy Issa, Andrew L. Young, Yanan Li, Infencia Xavier Raj, Christine R. Zhang, Aishwarya Krishnan et al. · 2026 · Blood Advances
  52. Additional file 1 of DNMT3A low-expression is correlated to poor prognosis in childhood B-ALL and confers resistance to daunorubicin on leukemic cells
    Li, Weijing, Liu, Shuguang, Wang, Chanjuan, Cui, Lei, Xiaoxi Zhao, Liu, Wei, Ruidong Zhang, Li, Zhigang · 2023 · Figshare
  53. Additional file 4 of The histone methyltransferase Setd8 alters the chromatin landscape and regulates the expression of key transcription factors during erythroid differentiation
    Myers, Jacquelyn A., Couch, Tyler, Zachary C. Murphy, Jeffrey T. Malik, Michael R. Getman, Laurie A. Steiner · 2020 · Figshare
  54. Additional file 3 of The histone methyltransferase Setd8 alters the chromatin landscape and regulates the expression of key transcription factors during erythroid differentiation
    Myers, Jacquelyn A., Couch, Tyler, Zachary C. Murphy, Jeffrey T. Malik, Michael R. Getman, Laurie A. Steiner · 2020 · Figshare
  55. Additional file 1 of The histone methyltransferase Setd8 alters the chromatin landscape and regulates the expression of key transcription factors during erythroid differentiation
    Myers, Jacquelyn A., Couch, Tyler, Zachary C. Murphy, Jeffrey T. Malik, Michael R. Getman, Laurie A. Steiner · 2020 · Figshare
  56. Additional file 2 of The histone methyltransferase Setd8 alters the chromatin landscape and regulates the expression of key transcription factors during erythroid differentiation
    Myers, Jacquelyn A., Couch, Tyler, Zachary C. Murphy, Jeffrey T. Malik, Michael R. Getman, Laurie A. Steiner · 2020 · Figshare
  57. CTRP1 regulates skeletal muscle differentiation through quality control of mitochondrial dynamics and function
    Sora Han, Youjeong Jang, Hyun Jeong Joo, Hye In Ka, Se Hwan Mun, Hai-Anh Nguyen, Doyeon Park, Yoohyun Jung, Doyeong Ko, Bo Ram Sohn et al. · 2026 · Molecular Therapy
  58. Rôle du long ARN non-codant CRNDE dans le myélome multiple
    Antoine David · 2019 · theses.fr (ABES)
  59. Analyse protéomique et interactomique de l'activation des lymphocytes T humains primaires
    Philippe Nicolas · 2021
  60. Reciprocal compensation of caspase-2 and p53 regulates the DNA damage response in HCT116 colon cancer cells
    Karla E. Lopez, Leslie Bandera, Luiza E. Coutinho, Karen Zúñiga, Sarah Wright, Lisa Bouchier‐Hayes · 2026 · Journal of Biological Chemistry
  61. CRISPR/Cas9 gene editing in hematopoietic stem and progenitor cells to accelerate the translation of cellular therapies and immunotherapies
    Laura Falceto Font, Dan Jin, John Figg, Connor P. Francis, Kaytora Long-James, Jeffrey Drake, Alexandra Reid, Caitland Love, Brianna McDonald, David Hilferty et al. · 2026 · Journal of Translational Research
  62. Turning Cold Tumors Into Hot Tumors: Implications for Cancer Therapy
    Xiao Ge, Dong Han, Jing Wang, Xinyu Dai, Chen Ma, Feihong Chen · 2026 · MedComm
  63. Nuclear RSK1 mediates interferon-γ–induced proinflammatory activation in human primary macrophages and humanized mice
    Keishi Nihira, Yoshihiro Yanagihara, Yuto Nakamura, Sarvesh Chelvanambi, Arda Halu, Lang Ho Lee, Alexander Mojcher, Hideyuki Higashi, Iwao Yamada, Jiao Qiao et al. · 2026 · Science Advances
  64. VMP1 restricts STING trafficking and activation through controlling CDIPT recruitment to ER membrane curvature
    Chen Zhou, Dongsheng Bai, Jiawei Zhao, HongJie Yin, Jiaying Du, Chunyang Gu, Yuxiang Wang, Binyan Lin, Na Lu, Yue Zhao · 2026 · Cell Death and Differentiation